Bio-Techne Q2 Results Miss Estimates; Declares Dividend

Bio-Techne Files Drug Master File With FDA For ExCellerate GMP IPSC Expansion Medium

Bio-Techne Corp. (TECH) announced Wednesday that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) for its ExCellerate GMP iPSC Expansion Medium, Animal Free (CCM0036-GMP), supporting the development and manufacture of regenerative medicine and stem cell therapies.

RTTNews | 663 dias atrás

Bio-Techne Promotes Kim Kelderman To Succeed Chuck Kummeth As President And CEO

Bio-Techne Corp. (TECH) announced Thursday that its Board of Directors appointed Kim Kelderman as President and Chief Executive Officer, effective February 1, 2024. Kelderman will also become a member of the Board of Directors on the same day.

RTTNews | 725 dias atrás

Bio-Techne, Akoya To End Co-development Of RNAscope For Use With PhenoCycler-Fusion System

Life sciences company Bio-Techne Corp. (TECH) announced Monday that the company will end their collaboration with Akoya Biosciences to co-develop an automated RNAscope workflow for use with the PhenoCycler-Fusion System. The decision was made following best efforts to achieve the intended program goals.

RTTNews | 791 dias atrás

Bio-Techne To Acquire Namocell For Undisclosed Terms

Life sciences company Bio-Techne Corp. (TECH) announced Wednesday it has reached an agreement to acquire Namocell, Inc., a provider of fast and easy to use single cell sorting and dispensing platforms that are gentle to cells, and preserve cell viability and integrity.

RTTNews | 1209 dias atrás

Australian Market Modestly Lower

The Australian stock market is trading modestly lower on Tuesday, adding to the losses in the previous two sessions, despite the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying well below the 8,900 level, with weakness in energy, financial and technology stocks partially offset by gains in mining stocks.

RTTNews | 20 minutos atrás